Effettuare il login Iscriviti gratis

Last updated: 8 September 2022 at 2:18pm EST

Margaret Faye Wilson Net Worth




The estimated Net Worth of Margaret Faye Wilson is at least $10.9 Mille dollars as of 19 October 2016. Ms. Wilson owns over 13,636 units of Biocept Inc stock worth over $10,902 and over the last 11 years she sold BIOC stock worth over $0. In addition, she makes $0 as Lead Independent Director at Biocept Inc.

Ms. Wilson BIOC stock SEC Form 4 insiders trading

Margaret has made over 2 trades of the Biocept Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently she bought 13,636 units of BIOC stock worth $15,000 on 19 October 2016.

The largest trade she's ever made was buying 13,636 units of Biocept Inc stock on 19 October 2016 worth over $15,000. On average, Margaret trades about 1,357 units every 47 days since 2014. As of 19 October 2016 she still owns at least 25,067 units of Biocept Inc stock.

You can see the complete history of Ms. Wilson stock trades at the bottom of the page.





Margaret Faye Wilson biography

Margaret Faye Wilson CPA serves as Lead Independent Director of the Company. Ms. Wilson is retired CEO of Wilson Boyles and Company, a business consulting firm specializing in the development and implementation of successful business strategies. Prior to co-founding Wilson Boyles in 2003, she served as Senior Vice-President, Value Initiatives and Risk Management for The Home Depot, having joined the company in 1998 following a 21-year career at Bank of America. Ms. Wilson was Executive-Vice President of Bank of America and Chairman and President of Security Pacific Financial Services, a wholly owned subsidiary of BancAmerica Corporation. Ms. Wilson began her banking career as a management trainee in the Corporate Banking Group of Security Pacific National Bank, which merged with and became Bank of America in 1992. Prior to assuming the chairmanship of Security Pacific Financial Services, she was the Executive Vice-President responsible for overseeing credit quality and policy for over 80% of Bank of America’s loan portfolio. During her Security Pacific career, Ms. Wilson spent time in London as the Managing Director of Corporate Finance for Security Pacific Hoare Govett, where she created new corporate advisory services, debt structuring products and formed a cross-border mergers and acquisitions division for European and U.S. companies. Prior to the London assignment, she was Managing Director of the Leveraged Buyout Group for the Security Pacific Merchant Bank, establishing the bank as lead in high profile transactions. Earlier, as Senior Vice-President and Regional Manager in the Corporate Banking Division with responsibility for multinational corporations, retail industry companies and California based corporations, Ms. Wilson established lead banking relationships with major players in those markets.



How old is Margaret Wilson?

Margaret Wilson is 82, she's been the Lead Independent Director of Biocept Inc since 2009. There are no older and 19 younger executives at Biocept Inc.

What's Margaret Wilson's mailing address?

Margaret's mailing address filed with the SEC is C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO, CA, 92121.

Insiders trading at Biocept Inc

Over the last 11 years, insiders at Biocept Inc have traded over $2,456 worth of Biocept Inc stock and bought 1,703,300 units worth $1,869,312 . The most active insiders traders include Claire Reiss, Edward A. Neff e David F Hale. On average, Biocept Inc executives and independent directors trade stock every 92 days with the average trade being worth of $27,462. The most recent stock trade was executed by David F Hale on 9 December 2021, trading 445 units of BIOC stock currently worth $1,807.



What does Biocept Inc do?

biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar



What does Biocept Inc's logo look like?

Biocept Inc logo

Complete history of Ms. Wilson stock trades at Biocept Inc

Data
#
Ditta
 Persona
Trans.
Transazione
 Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
19 Oct 2016 BIOC Biocept Inc Margaret Faye Wilson
Direttore
 Acquistare 13,636 $1.10 $15,000
19 Oct 2016
25,067 ↗
13 Feb 2015 BIOC Biocept Inc Margaret Faye Wilson
Direttore
 Acquistare 4,000 $1.25 $5,000
13 Feb 2015
9,074 ↗


Biocept Inc executives and stock owners

Biocept Inc executives and other stock owners filed with the SEC include: